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In the fast-growing field of nanomedicine, mucus is often the first barrier
encountered by drug products in the body, and can be the only barrier if it is not
overcome by the drug delivery system. Thus, there is a need to design new
nanomedicines that are able to diffuse easily across mucus to reach their
pharmacological targets. In this design process, mucus diffusion studies are
mandatory and have an important role in the selection of the best drug
candidates. However, there is currently no standard procedure for diffusion
studies across mucus. In this Foundation Review, we discuss the differences
observed within mucus models and experimental protocols in diffusion studies,
with an emphasis on nanomedicine diffusion.
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